Abstract
Corrigendum to “SARS-CoV-2 Mpro oligomerization as a potential target for therapy” [Int. J. Biol. Macromol. 267 (Part 1) (May 2024) 131392]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Biological Macromolecules
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.